Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1817241 · ARTV

Artiva Biotherapeutics, Inc.

Filing with the SEC SEC-reporting company San Diego, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • RestructuringOn Oct 27, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05): workforce reduction.
  • Net loss in 2025Net loss of $83.9M for the year (2024: −$65.4M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$0$251K
Net income (loss)−$83.9M−$65.4M
Total assets$131M$210M
Total liabilities$21M$22.9M
Stockholders’ equity$110M$187M
Cash and equivalents$26.7M$40.2M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Artiva Biotherapeutics, Inc.
CIK
0001817241
Tickers
ARTV
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
San Diego, California
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 27, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 9, 2026 · filing
  • Layoffs or restructuring: Workforce reduction
    Form 8-K · items 2.02, 2.05, 9.01 · filed Oct 27, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 9.01 · filed Oct 27, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Sep 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 19, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed May 8, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 8, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 10, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 24, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 19, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 6, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 25, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 24, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 24, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 29, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Oct 22, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 29, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 29, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jul 29, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jul 29, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jul 22, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 28, 2024 · filing